Harrow, Inc. Interest Payable, Current
Harrow, Inc. (HROW) had Interest Payable, Current of $7.69 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:InterestPayableCurrent · last filed 2026-08-10
- 2026-06-30: Interest Payable, Current $7.69M.
- 2026-03-31: Interest Payable, Current $1.22M.
- 2025-12-31: Interest Payable, Current $6.50M.
- 2025-09-30: Interest Payable, Current $1.06M.
| Period end | Interest Payable, Current | Interest Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $7.69M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $1.22M 10-Q · filed 2026-05-11 | |
| 2025-12-31 | $6.50M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $1.06M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $1.89M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $1.96M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $2.54M 10-K · filed 2026-03-02 | $36.22M 10-K · filed 2025-03-27 |
| 2024-09-30 | $37.90M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $43.51M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $48.69M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $53.97M 10-K · filed 2024-03-19 | |
| 2023-09-30 | $59.23M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $60.00M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $63.64M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $41.77M 10-K · filed 2023-03-23 | |
| 2022-09-30 | $23.18M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $24.80M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $26.42M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $28.03M 10-K · filed 2022-03-10 | |
| 2021-09-30 | $31.19M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $31.73M 10-Q · filed 2021-08-10 | |
| 2021-03-31 | $2.51M 10-Q · filed 2021-05-11 | |
| 2020-12-31 | $2.93M 10-K · filed 2021-03-08 | |
| 2020-09-30 | $3.02M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $3.48M 10-Q · filed 2020-08-10 | |
| 2018-03-31 | -$7.22M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$7.46M 10-K · filed 2018-03-08 | |
| 2017-09-30 | -$7.95K 10-Q · filed 2017-11-14 | |
| 2012-04-20 | $762.53K 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |